China’s medical insurance enforcement in 2026: New rules, active campaign, and implications for pharmaceutical companies

The Implementing Rules and the concurrent enforcement Campaign introduce the most operationally detailed medical insurance fraud supervision framework China has seen. Phase 1 of the Campaign is active through July 2026. Article 41 of the Implementing Rules creates a mandatory criminal referral mechanism. Medical insurance authorities must refer cases to the public security organs upon detecting specified behaviors, including organizing, participating in, or facilitating certain enumerated... By: Hogan Lovells